The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKier Regulatory News (KIE)

Share Price Information for Kier (KIE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 134.60
Bid: 134.00
Ask: 134.60
Change: 3.80 (2.91%)
Spread: 0.60 (0.448%)
Open: 133.00
High: 135.00
Low: 131.00
Prev. Close: 130.80
KIE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Kier Announces Proposed Offer of Senior Notes

5 Feb 2024 08:03

RNS Number : 0183C
Kier Group PLC
05 February 2024

NOT FOR PUBLICATION, DISTRIBUTION OR CIRCULATION IN

UNITED STATES, AUSTRALIA, CANADA OR JAPAN

Kier Group plc Announces Proposed Offer of Senior Notes

5 February 2024

Kier Group plc ("Kier" or the "Issuer"), a leading UK infrastructure services, construction and property group providing specialist design, build capabilities and project management, is pleased to announce that it intends to offer £250.0 million in aggregate principal amount of senior notes due 2029 (the "Notes") as part of a wider refinancing of the Issuer's existing committed debt facilities.

The interest rate, offering price and certain other terms will be determined at the time of pricing the Notes, subject to market conditions. The Issuer intends to use the proceeds from the offering of the Notes to partially prepay certain elements of its existing credit facilities and private placement notes. The Notes will be general unsecured senior obligations of the Issuer and will be guaranteed on a senior basis by certain subsidiaries of the Issuer.

For further enquiries please contact:

Investor Relations

+44 (0)7933 388 746

Kier Press Office

+44 (0)1767 355 096

Richard Mountain, FTI Consulting

+44 (0)203 727 1340

Kier Group plc

LEI: 2138002RKCU2OM4Y7O48.

Ends

The Notes and the guarantees thereof will not be registered under the United States Securities Act of 1933, as amended (the "Securities Act"), or applicable state securities laws. Accordingly, the Notes will be offered only to persons outside the United States in reliance on Regulation S under the Securities Act. Unless so registered, the Notes may not be offered or sold in the United States.

This announcement does not constitute an offer to sell or the solicitation of an offer to buy the Notes or any other security and shall not constitute an offer, solicitation or sale in the United States or in any jurisdiction in which, or to any persons to whom, such offering, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any jurisdiction.

The securities are not intended to be offered, sold or otherwise made available to and should not be offered, sold or otherwise made available to any retail investor in the European Economic Area ("EEA"). For these purposes, a retail investor means a person who is one (or more) of: (i) a retail client as defined in point (11) of Article 4(1) of Directive 2014/65/EU (as amended, "MiFID II") or (ii) a customer within the meaning of Directive 2016/97/EU (as amended), where that customer would not qualify as a professional client as defined in point (10) of Article 4(1) of MiFID II. Consequently, no key information document required by Regulation (EU) No 1286/2014 (as amended, the "PRIIPs Regulation") for offering or selling the securities or otherwise making them available to retail investors in the EEA has been prepared and therefore offering or selling the securities or otherwise making them available to any retail investor in the EEA may be unlawful under the PRIIPS Regulation.

In member states of the EEA, this announcement and any offer of the securities referred to herein in any Member State of the EEA will be made pursuant to an exemption under Regulation (EU) 2017/1129 (the "Prospectus Regulation") from the requirement to publish a prospectus for offers of the securities referred to herein. Accordingly, any person making or intending to make an offer in a Member State of Notes which are the subject of the offering contemplated may only do so in circumstances in which no obligation arises for the Issuer or any of the initial purchasers to publish a prospectus pursuant to Article 3 of the Prospectus Regulation, in each case, in relation to such offer. Neither the Issuer nor the initial purchasers have authorized, nor do they authorize, the making of any offer of Notes in circumstances in which an obligation arises for the Issuer or the initial purchasers to publish a prospectus for such offer.

The securities are not intended to be offered, sold or otherwise made available to and should not be offered, sold or otherwise made available to any retail investor in the United Kingdom ("UK"). For these purposes, a retail investor means a person who is one (or more) of: (i) a retail client, as defined in point (8) of Article 2 of Regulation (EU) No 2017/565 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018 ("EUWA"); or (ii) a customer within the meaning of the provisions of the FSMA and any rules or regulations made under the FSMA to implement Directive (EU) 2016/97, where that customer would not qualify as a professional client, as defined in point (8) of Article 2(1) of Regulation (EU) No 600/2014 as it forms part of domestic law by virtue of the EUWA. Consequently no key information document required by Regulation (EU) No 1286/2014 as it forms part of domestic law by virtue of the EUWA (the "UK PRIIPs Regulation") for offering or selling the Notes or otherwise making them available to retail investors in the UK has been prepared and therefore offering or selling the Notes or otherwise making them available to any retail investor in the UK may be unlawful under the UK PRIIPs Regulation.

In the UK, this announcement and any offer of the securities referred to herein in the UK will be made pursuant to an exemption under Regulation (EU) 2017/1129 as it forms part of domestic law by virtue of the EUWA (the "UK Prospectus Regulation") from the requirement to publish a prospectus for offers of the securities referred to herein. Accordingly, any person making or intending to make an offer in the UK of Notes which are the subject of the offering contemplated may only do so in circumstances in which no obligation arises for the Issuer or any of the initial purchasers to publish a prospectus pursuant to Article 3 of the UK Prospectus Regulation, in each case, in relation to such offer. Neither the Issuer nor the initial purchasers have authorized, nor do they authorize, the making of any offer of Notes in circumstances in which an obligation arises for the Issuer or the initial purchasers to publish a prospectus for such offer.

This announcement is being distributed only to, and is directed only at persons who (i) have professional experience in matters relating to investments falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the "Financial Promotion Order") (ii) are persons falling within Article 49(2)(a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Promotion Order, (iii) are outside the United Kingdom or (iv) are persons to whom an invitation or inducement to engage in investment activity (within the meaning of section 21 of the Financial Services and Markets Act 2000 in connection with the issue and sale of any securities may otherwise lawfully be communicated or caused to be communicated (all such persons together being referred to as "relevant persons"). This announcement is directed only at relevant persons and must not be acted on or relied on by persons who are not relevant persons. Any investment or investment activity to which this announcement relates is available only to relevant persons and will be engaged in only with relevant persons.

Neither the content of the Issuer's website nor any website accessible by hyperlinks on the Issuer 's website is incorporated in, or forms part of, this announcement. The distribution of this announcement into certain jurisdictions may be restricted by law. Persons into whose possession this announcement comes should inform themselves about and observe any such restrictions. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.

This announcement may include projections and other "forward-looking" statements within the meaning of applicable securities laws. Any such projections or statements reflect the current views of the Issuer about future events and financial performance. The use of any of the words "expect," "anticipate," "continue," "will," "project," "should," "believe," "plans," "intends" and similar expressions are intended to identify forward-looking information or statements. Although the Issuer believes that the expectations and assumptions on which such forward-looking statements and information are reasonable, undue reliance should not be placed on the forward-looking statements and information because the Issuer can give no assurance that such statements and information will prove to be correct. Since forward-looking statements and information address future events and conditions, by their very nature they involve inherent risks and uncertainties.

The forward-looking statements and information contained in this announcement are made as of the date hereof and the Issuer undertakes no obligation to update publicly or revise any forward-looking statements or information, whether as a result of new information, future events or otherwise, unless so required by applicable securities laws.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
MSCEAXASESXLEEA
Date   Source Headline
17th Apr 202412:30 pmRNSDirector/PDMR Shareholding
8th Apr 202411:26 amRNSDirector/PDMR Shareholding
5th Apr 202410:15 amRNSDirector/PDMR Shareholding
2nd Apr 20243:19 pmRNSDirector/PDMR Shareholding
2nd Apr 20241:00 pmRNSTotal Voting Rights
20th Mar 20245:48 pmRNSDirector/PDMR Shareholding
19th Mar 202410:12 amRNSDirector/PDMR Shareholding
15th Mar 20248:40 amRNSPost Stabilisation Notice
11th Mar 202410:37 amRNSBlock Listing Application
7th Mar 20247:00 amRNSResults for the period ended 31 December 2023
1st Mar 202410:11 amRNSTotal Voting Rights
1st Mar 20247:00 amRNSGreen Economy Mark and SBTi certifications
20th Feb 20241:43 pmRNSDirector/PDMR Shareholding
15th Feb 202411:05 amRNSKier Group plc successfully issues Senior Notes
15th Feb 202410:09 amRNSHolding(s) in Company
8th Feb 20245:22 pmRNSKier Group plc Announces Pricing of Senior Notes
6th Feb 202410:59 amRNSPre Stabilisation Notice
5th Feb 20248:03 amRNSKier Announces Proposed Offer of Senior Notes
1st Feb 20242:16 pmRNSTotal Voting Rights
22nd Jan 202410:30 amRNSDirector/PDMR Shareholding
18th Jan 20247:00 amRNSTrading Update
5th Jan 202411:47 amRNSHolding(s) in Company
2nd Jan 20243:44 pmRNSBlock listing Interim Review
2nd Jan 20243:42 pmRNSTotal Voting Rights
27th Dec 202310:10 amRNSReduction of Capital
27th Dec 202310:05 amRNSHolding(s) in Company
27th Dec 202310:02 amRNSHolding(s) in Company
21st Dec 202312:21 pmRNSDirector/PDMR Shareholding
19th Dec 20233:57 pmRNSDirector/PDMR Shareholding
18th Dec 20234:50 pmRNSDirector/PDMR Shareholding
14th Dec 202310:35 amRNSDirectorate Change
1st Dec 202310:53 amRNSTotal Voting Rights
22nd Nov 202311:09 amRNSDirector/PDMR Shareholding
20th Nov 20233:10 pmRNSDirector/PDMR Shareholding
16th Nov 20234:00 pmRNSResult of AGM
16th Nov 20237:00 amRNSAGM Trading Update
1st Nov 202312:28 pmRNSTotal Voting Rights
1st Nov 202312:24 pmRNSDirector/PDMR Shareholding
30th Oct 20234:00 pmRNSDirector/PDMR Shareholding
24th Oct 20239:37 amRNSHolding(s) in Company
20th Oct 202312:00 pmRNSDirector/PDMR Shareholding
10th Oct 202310:09 amRNSHolding(s) in Company
6th Oct 20232:34 pmRNSAnnual Financial Report
2nd Oct 202311:15 amRNSTotal Voting Rights
22nd Sep 20232:00 pmRNSDirector/PDMR Shareholding
22nd Sep 202310:09 amRNSHolding(s) in Company
20th Sep 20231:42 pmRNSHolding(s) in Company
20th Sep 20231:39 pmRNSDirector/PDMR Shareholding
15th Sep 20234:06 pmRNSDirector/PDMR Shareholding
14th Sep 20232:36 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.